Literature DB >> 18813502

[Impacts of non-transmissible chronic diseases on social security benefits].

Alda Alice Gomes de Moura1, Eduardo Freese de Carvalho, Neiton José Carvalho da Silva.   

Abstract

This paper strives to identify the current impact of Non-Transmissible Chronic Diseases (NTCDs) on sickness and disability benefits paid out by Brazil's National Social Security Institute (INSS) between 2000 and 2002. A total of 17,970 new cases were studied, registered at the two local agencies in Recife, Pernambuco State, Northeast Brazil. Initially the cases were divided up according by major diseases groups, following the CID-10 classification. Osteomuscular diseases (OMDs) and cardiovascular diseases (CVDs) were among the main reasons for granting sickness benefits. Among the disability benefits, CVDs, mental disorders (MDs), and OMDs, were the main reasons. In terms of specific diseases within the major DCNT groups, the main reasons for granting sickness benefits were high blood pressure, diabetes mellitus, arthrosis, breast and intestinal cancer, mood disorders and schizophrenia. For disability benefits, the main causes were cerebrovascular diseases, diabetes mellitus, cancer of the gastro-intestinal tract and schizophrenia. Most (66%) of the recipients were men between 39 and 58 years of age, and the initial value of the benefit was of up to three minimum wages per month.

Entities:  

Mesh:

Year:  2007        PMID: 18813502     DOI: 10.1590/s1413-81232007000600027

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  2 in total

1.  Benefits granted due to cardiovascular disease in Recife, Pernambuco, Brazil, 2011-2015.

Authors:  Adilson da Silva Morato; Simone Cristina Soares Brandão; Marcelo Tavares Vianna; Thiago Darlan Silveira da Silva; Adriana Gonçalves Velozo
Journal:  Rev Bras Med Trab       Date:  2018-06-01

2.  The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.

Authors:  Alberto Barcelo; Armando Arredondo; Amparo Gordillo-Tobar; Johanna Segovia; Anthony Qiang
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.